Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

NCT03462017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Microvascular Coronary Artery Disease

Interventions

DRUG: SAR247799
DRUG: Placebo
DRUG: Sildenafil
DRUG: Acetylcholine

Sponsor

Sanofi